Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001079973-25-000515

Chief Financial Officer bought 9,056 shares at $1.04 ($9,434)

From the SEC's structured data for this filing

Trades in this filing

Carter Robert Ross · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-03-26 Purchase : show line 1 in the form +9,056 $1.04 $9,434 39,407 D
Open-market purchases · 9,056 sh · avg $1.04 · $9,434

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-03-26 Purchase : show line 2 in the form Common Warrant +4,528 $0.13 $566 4,528 D
Loading xslF345X05/ownership.xml…